Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-07T22:57:11.513Z Has data issue: false hasContentIssue false

Hyperbaric oxygen therapy for sudden sensorineural hearing loss in large vestibular aqueduct syndrome

Published online by Cambridge University Press:  06 June 2013

H Shilton*
Affiliation:
Department of Surgery, Southern Health, Clayton, Victoria, Australia
M Hodgson
Affiliation:
Hyperbaric Medicine, Brunswick Private Hospital, Victoria, Australia
G Burgess
Affiliation:
Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
*
Address for correspondence: Dr H Shilton, Department of Surgery, Southern Health, Clayton Road, Clayton, Victoria, Australia3168 Fax: +61 3 9562 9599 E-mail: [email protected]

Abstract

Introduction:

We report the first use in Australia of hyperbaric oxygen therapy for sudden hearing loss following head trauma in a child with large vestibular aqueduct syndrome.

Case report:

A 12-year-old boy with large vestibular aqueduct syndrome presented with significant hearing loss following head trauma. He was treated with steroids and hyperbaric oxygen therapy, with good improvement of hearing thresholds on audiography. This case represents the first reported use of hyperbaric oxygen therapy for this indication in Australia, following a few previous reports of patients in Japan. We review the literature on management of acute sensorineural hearing loss in large vestibular aqueduct syndrome. The reported case demonstrates a potentially beneficial therapy for a rare condition that usually results in an inevitable decline in hearing.

Conclusion:

Hyperbaric oxygen therapy can be tolerated well by children, and may represent a potential treatment for sudden sensorineural hearing loss in patients with large vestibular aqueduct syndrome.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Nakashima, T, Ueda, H, Furuhashi, A, Yasue, M, Beppu, R, Ogawa, K et al. Large vestibular aqueduct syndrome treated by hyperbaric oxygen. Int J Pediatr Otorhinolaryngol 1999;51:207–10CrossRefGoogle ScholarPubMed
2Muzzi, E, Zennaro, B, Visentin, R, Soldano, F, Sacilotto, C. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol 2010;124:e2CrossRefGoogle ScholarPubMed
3Valvassori, GE, Clemis, JD. The large vestibular aqueduct syndrome. Laryngoscope 1978;88:723–8CrossRefGoogle ScholarPubMed
4Kim, SH, Song, DG, Bae, JW, Choi, SY, Kim, UK, Choi, YJ et al. A family of H723R mutation for SLC26A4 associated with enlarged vestibular aqueduct syndrome. Clin Exp Otorhinolaryngol 2009;2:100–2CrossRefGoogle ScholarPubMed
5Govaerts, PJ, Casselman, J, Daemers, K, De Ceulaer, G, Somers, T, Offeciers, FE. Audiological findings in large vestibular aqueduct syndrome. Int J Pediatr Otorhinolaryngol 1999;51:157–64CrossRefGoogle ScholarPubMed
6Levenson, MJ, Parisier, SC, Jacobs, M, Edelstein, DR. The large vestibular aqueduct syndrome in children. A review of 12 cases and the description of a new clinical entity. Arch Otolaryngol Head Neck Surg 1989;115:54–8CrossRefGoogle ScholarPubMed
7Madden, C, Halsted, M, Benton, C, Greinwald, J, Choo, D. Enlarged vestibular aqueduct syndrome in the pediatric population. Otol Neurotol 2003;24:625–32CrossRefGoogle ScholarPubMed
8Jackler, RK, De La Cruz, A. The large vestibular aqueduct syndrome. Laryngoscope 1989;99:1238–42CrossRefGoogle ScholarPubMed
9Asma, A, Anouk, H, Luc, VH, Brokx, JP, Cila, U, Van De Heyning, P. Therapeutic approach in managing patients with large vestibular aqueduct syndrome (LVAS). Int J Pediatr Otorhinolaryngol 2010;74:474–81CrossRefGoogle ScholarPubMed
10Welling, DB, Slater, PW, Martyn, MD, Antonelli, PJ, Gantz, BJ, Luxford, WM et al. Sensorineural hearing loss after occlusion of the enlarged vestibular aqueduct. Am J Otol 1999;20:338–43Google ScholarPubMed
11Jarvis, SJ, Giangrande, V, John, G, Thornton, AR. Management of acute idiopathic sensorineural hearing loss: a survey of UK ENT consultants. Acta Otorhinolaryngol Ital 2011;31:85–9Google ScholarPubMed
12Spear, SA, Schwartz, SR. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534–43CrossRefGoogle ScholarPubMed
13Wei, BP, Mubiru, S, O'Leary, S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006;(1):CD003998CrossRefGoogle ScholarPubMed
14Agarwal, L, Pothier, DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2009;(4):CD003422CrossRefGoogle ScholarPubMed
15Liu, SC, Kang, BH, Lee, JC, Lin, YS, Huang, KL, Liu, DW et al. Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clin Otolaryngol 2011;36:121–8CrossRefGoogle ScholarPubMed
16Alimoglu, Y, Inci, E, Edizer, DT, Ozdilek, A, Aslan, M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011;268:1735–41CrossRefGoogle ScholarPubMed
17Bennett, MH, Kertesz, T, Yeung, P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2007;(1):CD004739CrossRefGoogle ScholarPubMed
18Korpinar, S, Alkan, Z, Yigit, O, Gor, AP, Toklu, AS, Cakir, B et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 2011;268:41–7CrossRefGoogle ScholarPubMed
19Furuhashi, A, Sato, E, Nakashima, T, Miura, Y, Nakayama, A, Mori, N et al. Hyperbaric oxygen therapy for the treatment of large vestibular aqueduct syndrome. Undersea Hyperb Med 2001;28:195200Google ScholarPubMed